Skip to main content
. 2017 Aug 28;28(11):2852–2859. doi: 10.1093/annonc/mdx484

Figure 1.

Figure 1.

Local relapse-free survival and relapse-free survival in non-metastatic sarcoma patients according to the date of MDTB presentation. (A) Local relapse-free survival in patients presented to a MDTB before, versus after initiation of treatment. (B) Relapse-free survival in patients presented to a MDTB before, versus after initiation of treatment.